These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 16309525

  • 1. Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept).
    Pastor N, Betlloch I, Pascual JC, Blanes M, Bañuls J, Silvestre JF.
    Clin Exp Dermatol; 2006 Jan; 31(1):152-3. PubMed ID: 16309525
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of pyoderma gangrenosum with the anti-TNFalpha drug - Etanercept.
    Rogge FJ, Pacifico M, Kang N.
    J Plast Reconstr Aesthet Surg; 2008 Jan; 61(4):431-3. PubMed ID: 18358433
    [Abstract] [Full Text] [Related]

  • 3. Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis.
    Goldenberg G, Jorizzo JL.
    J Dermatolog Treat; 2005 Jan; 16(5-6):347-9. PubMed ID: 16428159
    [Abstract] [Full Text] [Related]

  • 4. Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series.
    Charles CA, Leon A, Banta MR, Kirsner RS.
    Int J Dermatol; 2007 Oct; 46(10):1095-9. PubMed ID: 17910724
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of etanercept for treatment of PAPA syndrome.
    Tofteland ND, Shaver TS.
    J Clin Rheumatol; 2010 Aug; 16(5):244-5. PubMed ID: 20661073
    [No Abstract] [Full Text] [Related]

  • 7. The use of etanercept in the treatment of peristomal pyoderma gangrenosum.
    Kim FS, Pandya AG.
    Clin Exp Dermatol; 2012 Jun; 37(4):442-3. PubMed ID: 22582915
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of thalidomide resistant pyoderma gangrenosum with etenercept.
    Guedes R, Moreira A, Menezes N, Baptista A, Varela P.
    Acta Dermatovenerol Croat; 2012 Jun; 20(3):175-80. PubMed ID: 23069303
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The treatment of pyoderma gangrenosum using etanercept.
    Roy DB, Conte ET, Cohen DJ.
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S128-34. PubMed ID: 16488326
    [No Abstract] [Full Text] [Related]

  • 11. Etanercept in psoriasis treatment.
    Pietrzak A, Chodorowska G, Urban J, Roliński J, Pietrzak B.
    Ann Univ Mariae Curie Sklodowska Med; 2003 Mar; 58(1):222-6. PubMed ID: 15314989
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Successful treatment of delayed pressure urticaria with anti-TNF-alpha.
    Magerl M, Philipp S, Manasterski M, Friedrich M, Maurer M.
    J Allergy Clin Immunol; 2007 Mar; 119(3):752-4. PubMed ID: 17336621
    [No Abstract] [Full Text] [Related]

  • 14. Successful biologic treatment of ocular mucous membrane pemphigoid with anti-TNF-alpha.
    John H, Whallett A, Quinlan M.
    Eye (Lond); 2007 Nov; 21(11):1434-5. PubMed ID: 17693996
    [No Abstract] [Full Text] [Related]

  • 15. Adolescent plaque psoriasis: our experience using etanercept.
    Ruiz-Villaverde R, Sánchez-Cano D, Abalos-Medina G.
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):976-7. PubMed ID: 19207668
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.
    Spadaro A, Ceccarelli F, Scrivo R, Valesini G.
    Ann Rheum Dis; 2008 Nov; 67(11):1650-1. PubMed ID: 18854519
    [No Abstract] [Full Text] [Related]

  • 18. Severe pyoderma gangrenosum unresponsive to etanercept and adalimumab.
    Kleinpenning MM, Langewouters AM, Van De Kerkhof PC, Greebe RJ.
    J Dermatolog Treat; 2011 Oct; 22(5):261-5. PubMed ID: 20673157
    [Abstract] [Full Text] [Related]

  • 19. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A, Perez VL, Hammel JP, Lowder CY.
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [Abstract] [Full Text] [Related]

  • 20. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
    Molloy ES, Langford CA, Clark TM, Gota CE, Hoffman GS.
    Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.